Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

inhalation

inhalation is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 8
Pipeline programs 63
News articles 0
Drug details — inhalation
Class
—
Route
—
Patents
8
Programs
63
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

inhalation is an FDA-listed pharmaceutical active ingredient.

Key facts

INN inhalation

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 222725 Phase 3 · GSK Glaxo Smith · Chronic Obstructive Pulmonary Disease
  2. 224295 Phase 3 · GSK Glaxo Smith · Chronic Obstructive Pulmonary Disease
  3. APHP 180610 Phase 3 · PARItec · Acute Myocardial Infarction
  4. APHP 180610 Phase 3 · PARItec · Acute Myocardial Infarction
  5. APHP230844 Phase 3 · PARItec · Adult patients with severe cardiogenic shock on venoarterial
  6. Amikacin Inhalation Solution (BAY41-6551) Phase 3 · Nektar Therapeutics UK · Pneumonia, Bacterial
  7. Armstrong Albuterol Sulfate Inhalation Aerosol Phase 3 · Amphastar France Pharmaceuticals · Asthma
  8. CLI-05993AA5-06 Phase 3 · Chiesi Farmaceutici S.p.A · Uncontrolled Asthma

Related patents

Browse patents

  1. EP 4210672

    HYALURONSÄURE ODER SALZ DAVON ZUR INHALATION ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN UND INHALATORVORRICHTUNG DAMIT

    Expires Tue Jul 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11253506

    Compounds, compositions and methods for preventing and/or treating chlorine inhalation toxicity and/or injury

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10799511

    Methods for reducing or ameliorating mortality and/or morbidity due to chlorine inhalation

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10111957

    Inhalation compositions comprising glucose anhydrous

    Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10105316

    Inhalation compositions comprising muscarinic receptor antagonist

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. CA 2866861

    TRAITEMENT DES MIGRAINES CHRONIQUES PAR INHALATION D'OXYGENE

    Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 6756033

    Method for delivering benzindene prostaglandins by inhalation

    Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6521212

    Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation

    Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is inhalation?

inhalation is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.